Skip to main content

Table 1 Baseline characteristics of subjects among the 4 LCA-derived AKI classes

From: Association of latent class analysis-derived subphenotypes of acute kidney injury with mortality in critically ill patients with cardiovascular disease: a retrospective cohort study

Variables

Class 1

Class 2

Class 3

Class 4

p

Number

3321

1401

2466

550

 

Age, years

68.67 ± 10.54

64.24 ± 14.23

68.68 ± 13.72

70.50 ± 12.59

 < 0.001

Male

2462 (74.1)

742 (53.0)

1394 (56.5)

354 (64.4)

 < 0.001

Body mass index, kg/m2

29.46 ± 5.93

28.75 ± 6.67

29.18 ± 7.41

30.47 ± 8.12

 < 0.001

CSRU

3198 (96.3)

1368 (97.6)

523 (21.2)

147 (26.7)

 < 0.001

Heart rate, /min

85.63 ± 8.95

83.84 ± 10.98

82.54 ± 16.39

80.29 ± 15.77

 < 0.001

Respiratory rate, /min

16.95 ± 2.68

16.95 ± 2.94

19.31 ± 3.80

19.10 ± 3.89

 < 0.001

SpO2, %

98.04 ± 1.39

98.01 ± 1.33

96.84 ± 2.23

97.03 ± 2.77

 < 0.001

Temperature, °C

36.87 ± 0.47

36.85 ± 0.55

36.81 ± 0.67

36.60 ± 0.69

 < 0.001

Glucose, mg/dL

132.63 ± 21.00

128.59 ± 20.67

148.59 ± 47.06

149.27 ± 50.64

 < 0.001

Systolic blood pressure, mmHg

112.09 ± 8.64

111.97 ± 9.54

115.95 ± 16.45

114.78 ± 17.71

 < 0.001

Diastolic blood pressure, mmHg

56.02 ± 6.04

57.54 ± 6.92

60.46 ± 10.57

55.45 ± 11.01

 < 0.001

Urine output, mL

1945.00 (1458.50–2636.00)

1840.00 (1305.00–2627.50)

1559.00 (996.75–2404.25)

835.50 (247.25–1589.75)

 < 0.001

Ventilation

3285 (98.9)

1386 (98.9)

814 (33.0)

268 (48.7)

 < 0.001

Vasopressor

2906 (87.5)

1065 (76.0)

648 (26.3)

265 (48.2)

 < 0.001

Sedative

3204 (96.5)

1367 (97.6)

691 (28.0)

226 (41.1)

 < 0.001

Furosemide

566 (17.0)

292 (20.8)

228 (9.2)

82 (14.9)

 < 0.001

CAD

3302 (99.4)

69 (4.9)

1282 (52.0)

253 (46.0)

 < 0.001

Atrial fibrillation

1428 (43.0)

658 (47.0)

866 (35.1)

231 (42.0)

 < 0.001

CHF

817 (24.6)

384 (27.4)

1226 (49.7)

364 (66.2)

 < 0.001

Hypertension

264 (7.9)

51 (3.6)

220 (8.9)

287 (52.2)

 < 0.001

Stroke

207 (6.2)

75 (5.4)

197 (8.0)

27 (4.9)

0.002

Sepsis

278 (8.4)

218 (15.6)

731 (29.6)

293 (53.3)

 < 0.001

Diabetes

1326 (39.9)

197 (14.1)

739 (30.0)

289 (52.5)

 < 0.001

COPD

317 (9.5)

137 (9.8)

406 (16.5)

91 (16.5)

 < 0.001

Renal disease

270 (8.1)

52 (3.7)

248 (10.1)

289 (52.5)

 < 0.001

Liver disease

32 (1.0)

27 (1.9)

56 (2.3)

31 (5.6)

 < 0.001

Malignancy

124 (3.7)

115 (8.2)

287 (11.6)

48 (8.7)

 < 0.001

Cardiopulmonary bypass

3150 (94.9)

1089 (77.7)

267 (10.8)

77 (14.0)

 < 0.001

CABG

3164 (95.3)

2 (0.1)

242 (9.8)

62 (11.3)

 < 0.001

Left heart catheterization

1435 (43.2)

177 (12.6)

1143 (46.4)

146 (26.5)

 < 0.001

White blood cell count, × 109/L

13.16 ± 5.15

13.08 ± 6.19

12.27 ± 6.03

12.78 ± 7.30

 < 0.001

Hemoglobin, g/dL

9.84 ± 2.04

9.93 ± 1.93

11.72 ± 1.99

10.03 ± 1.63

 < 0.001

Platelet, × 109/L

164.38 ± 60.03

161.50 ± 67.91

239.12 ± 101.52

219.03 ± 100.62

 < 0.001

Chloride, mg/dL

108.09 ± 3.96

108.65 ± 4.16

103.54 ± 5.16

101.58 ± 6.78

 < 0.001

Sodium, mg/dL

136.47 ± 2.78

137.52 ± 3.36

138.19 ± 4.23

136.30 ± 5.40

 < 0.001

Potassium, mg/dL

4.55 ± 0.82

4.34 ± 0.82

4.10 ± 0.65

4.69 ± 0.87

 < 0.001

BUN, mg/dL

17.49 ± 7.50

16.53 ± 7.00

23.20 ± 10.99

68.05 ± 23.68

 < 0.001

Bicarbonate, mg/dL

23.60 ± 2.39

23.36 ± 2.81

24.49 ± 4.61

22.00 ± 5.33

 < 0.001

Creatinine, mg/dL

0.80 (0.70–1.00)

0.80 (0.60–1.00)

1.00 (0.80–1.40)

3.30 (2.50–5.10)

 < 0.001

  1. Continuous variables are presented as the SEM ± SD or median (interquartile range), as appropriate. Categorical variables are presented as numbers (percentages). The chi-square test of categorical variables and analysis of variance or Kruskal–Wallis test of continuous variables were used for comparisons among groups. AKI, acute kidney injury; LCA, latent class analysis; CSRU, cardiac surgery recovery unit; CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; BUN, blood urea nitrogen